AI Article Synopsis

  • Diuron is identified as a likely human carcinogen, previously linked to cancers in various organs, but its impact on glioma occurrence had not been studied until now.
  • Diuron alone does not induce glioma; however, when combined with known oncogene overexpression (like Akt), it promotes glioma development with distinct cancer cell characteristics, including global DNA hypomethylation and immune escape signals.
  • Three specific hypomethylation signatures linked to diuron exposure were found in glioblastoma patients, suggesting that occupational exposure to diuron may increase glioma risk when coupled with other oncogenic factors.

Article Abstract

Background: Diuron is an environmental component listed as a likely human carcinogen. Several other studies report that diuron can be oncogenic for bladder, urothelial, skin, and mammary cells. No study mentions the putative effect of diuron on the glioma occurrence.

Objectives: We here wanted to investigate the effects of diuron exposure on the glioma occurrence while wishing to incriminate a putative implication of DNA methylation modulation in this process.

Methods: In in vivo model of glioma, diuron exposure was firstly compared or combined with oncogenic overexpressions already known to promote gliomagenesis. ELISA quantifying the 5-methylcytosine level on DNA was performed to examine the global DNA methylation level. Quantitative real-time polymerase chain reaction and proximity ligation in situ assay were performed to identify the molecular causes of the diuron-induced changes of DNA methylation. The signatures diuron-induced changes of DNA methylation were analyzed in a cohort of 23 GBM patients.

Results: Diuron exposure is not sufficient to promote glioma, such as the oncogenic overexpression of Akt or Ras. However, the combination of diuron exposure and Akt overexpression promotes glioma. We observed that the diuron/Akt-induced glioma is characterized by three phenotypic signatures characterizing cancer cells: a global DNA hypomethylation, a loss of sensitivity to cell death induction, and a gain of signals of immune escape. Our data associated these phenotypes with three aberrant DNA methylation signatures: the LLT1, PD-L1, and Bcl-w hypomethylations. Strikingly, we observed that these three concomitant hypomethylations were only observed in GBM patients having a potential exposure to diuron via their professional activity.

Conclusions: As single player, diuron is not an oncogenic of glioma, but it can participate to the glioma formation in association with other events (also devoid of oncogenic property as single player) such as Akt overexpression.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854743PMC
http://dx.doi.org/10.1186/s13148-019-0759-1DOI Listing

Publication Analysis

Top Keywords

diuron exposure
20
dna methylation
20
akt overexpression
12
diuron
10
glioma
9
exposure akt
8
promote glioma
8
glioma formation
8
dna
8
dna hypomethylation
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!